Results 101 to 110 of about 59,572 (271)
Frontiers in Psychiatry, 2017 The authors present the case of a 24-year-old male with treatment-resistant schizophrenia, with predominant severe delusion and hallucination, who received bone marrow transplantation (BMT) for acute myeloid leukemia.
Tsuyoshi Miyaoka +11 more
doaj +1 more source
Treatment-resistant schizophrenia: current insights on the pharmacogenomics of antipsychotics
, 2016 John Lally,1–3 Fiona Gaughran,1,3 Philip Timms,4,5 Sarah R Curran5–7 1Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King’s College London, London, UK; 2Department of Psychiatry, Royal College of ...
Timms P, Lally J, Gaughran F, Curran SR
core
Is there a role for cannabidiol in obesity, metabolic syndrome and binge eating?
British Journal of Pharmacology, EarlyView.Cannabidiol (CBD) is one of the most abundant phytocannabinoids isolated from the Cannabis sativa plant. CBD is a lipophilic, non‐intoxicating substance that differently from Δ9‐tetrahydrocannabinol (Δ9‐THC) does not present the typical profile of a drug of abuse.
Luca Botticelli +7 more
wiley +1 more source
Clinical and Biomedical Research, 2021 For years, the management of schizophrenia has represented a challenge for clinicians, with antipsychotic treatments usually resulting in relapses and new hospitalizations.
Marina Dalla Barba Londero +5 more
doaj
Treatment resistance in schizophrenia [PDF]
British Journal of Psychiatry, 1993 S, Mirza, V S, Babu, E, Vithayathil
openaire +2 more sources
Treatment resistance in Schizophrenia
European Psychiatry, 2011 DiagnosisThe diagnosis of treatment resistant schizophrenia generally follows two not always consistent lines of thinking: one is based on research strategies, the other one on every day clinical practice. Both require a failure to respond to at least two (sometimes three) treatment attempts of adequate duration with an adequate dose of an ...
openaire +1 more source
TREATMENT OF RESISTANT AND ULTRA RESISTANT SCHIZOPHRENIA
, 2021 Schizophrenia is a psychiatric disease which affects one percent of population. It is most common in young adults. It is primarily treated with typical and atypical antipsychotics.
Herceg, Dora +2 more
core
British Journal of Pharmacology, EarlyView.Abstract Background and Purpose Kinases phosphorylate ion channels, but their noncatalytic roles via protein–protein interactions (PPI) are less understood. Here, we identified the peptidomimetic ZL141 to characterize the PPI between GSK3β and Nav1.6, revealing a noncatalytic role for GSK3β in regulating Nav1.6 currents and neuronal excitability ...
Aditya K. Singh +19 more
wiley +1 more source
Indian Journal of Health Sciences and Biomedical Research KLEUAIM: The aim of the study was to study the efficacy of modified electroconvulsive therapy (MECT) as an augmentation agent in schizophrenia, with particular emphasis in treatment-resistant schizophrenia.
Chitrakshee Singh +3 more
doaj +1 more source
Treatment-resistant schizophrenia: pathogenesis and treatment strategies.
, 2021 Treatment-resistant schizophrenia (TRS) is most defined as an inadequate response in schizophrenia symptoms, despite adequate treatment with two or more antipsychotic medications.
Vasiliauskas, Erikas, +1 more
core